Clinical Trials Directory

Trials / Unknown

UnknownNCT05063214

Muscle Evaluation of Patients Infected by the Coronavirus

Muscle Evaluation of Patients Infected by the Coronavirus Requiring Mechanical Ventilation

Status
Unknown
Phase
Study type
Observational
Enrollment
138 (estimated)
Sponsor
Hospital Israelita Albert Einstein · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents risk to develop muscle weakness associated with prolonged period of mechanical ventilation support and hospital stay.

Detailed description

Intensive care unit (ICU) acquired muscle weakness affects both respiratory and peripheral muscles and can contribute to worsen clinical and functional outcomes. In this way, ultrasonography muscle evaluation could help to identify early alterations guiding the therapeutic planning and allowing to monitor the interventions performed. Therefore, the investigators intend to follow up mechanically ventilated patients with confirmed diagnosis of COVID-19 during ICU stay to quantify the diaphragm, parasternal intercostal, abdominals and femoral quadriceps muscles thickness assessed by ultrasonography. Additionally, functional capacity, frailty and level of physical activity will be evaluated and followed for pre-admission condition and 30, 90 and 180 days after hospital discharge .

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMuscle ultrasound evaluationMuscle ultrasound evaluation will be performed in patients admitted with COVID-19 requiring invasive mechanical ventilation. The measurements of thickness and thickening fraction will occur for diaphragm, abdominal - rectus abdominis, internal oblique, external oblique and transverse abdomen - and parasternal intercostal muscles. Serial measurements of the thickness and echogenicity of the quadriceps femoris muscle will also be performed.

Timeline

Start date
2021-09-30
Primary completion
2022-09-01
Completion
2022-09-01
First posted
2021-10-01
Last updated
2021-10-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT05063214. Inclusion in this directory is not an endorsement.